The Turing Lectures: AI for drug discovery Over the past few years we have witnessed the rise of AI and the enormous efficiency it can bring to drug discovery and development. While we are starting to see fruitful applications and preliminary success, the field is still in its infancy. This talk will introduce AI in drug discovery and its exciting potential. We will also touch on AI limitations and propose approaches to scale AI to address diseases with unmet needs. Nov 30 2021 15.00 - 16.30 The Turing Lectures: AI for drug discovery Noor Shaker is a serial biotech entrepreneur and the CEO at GlamorousAI, a biotech company that pushes the boundaries to what is possible with AI to cure debilitating diseases. She is a recognised healthcare leader, MIT innovator under 35 and in BBC 100 women. Online Register
The Turing Lectures: AI for drug discovery Over the past few years we have witnessed the rise of AI and the enormous efficiency it can bring to drug discovery and development. While we are starting to see fruitful applications and preliminary success, the field is still in its infancy. This talk will introduce AI in drug discovery and its exciting potential. We will also touch on AI limitations and propose approaches to scale AI to address diseases with unmet needs. Nov 30 2021 15.00 - 16.30 The Turing Lectures: AI for drug discovery Noor Shaker is a serial biotech entrepreneur and the CEO at GlamorousAI, a biotech company that pushes the boundaries to what is possible with AI to cure debilitating diseases. She is a recognised healthcare leader, MIT innovator under 35 and in BBC 100 women. Online Register
Nov 30 2021 15.00 - 16.30 The Turing Lectures: AI for drug discovery Noor Shaker is a serial biotech entrepreneur and the CEO at GlamorousAI, a biotech company that pushes the boundaries to what is possible with AI to cure debilitating diseases. She is a recognised healthcare leader, MIT innovator under 35 and in BBC 100 women.
